Phase 3 EDELWEISS 3 trial results of linzagolix
ObsEva will host a conference call and audio webcast Thursday 6th January beginning at 8:00 a.m. Eastern Time/2:00 p.m. Central European Time to discuss Phase 3 EDELWEISS 3 trial results of linzagolix. Investors may participate by dialing 1-877-407-9208 for U.S. callers or +1-201-493-6784 for international callers and referring to conference ID 13725902.
Please click here to access webcast